Protocol for the Stimulating β3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease

Código QR

Protocol for the Stimulating β3-Adrenergic Receptors for Peripheral Artery Disease (STAR-PAD) trial: a double-blinded, randomised, placebo-controlled study evaluating the effects of mirabegron on functional performance in patients with peripheral arterial disease

Guardado en:

Detalles Bibliográficos
Autores principales:	Clara Chow, Anthony C Keech, Laurent Billot, Sanjay Patel, Kristen J Bubb, Stuart M Grieve, Gemma A Figtree, Jonathan Golledge, Jason A Harmer, Meghan Finemore, Sarah Joy Aitken, Zara S Ali, Rebecca Mister, Michael P Gray, Naomi Hamburg, Vikram Puttaswamy
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Medicine R
Acceso en línea:	https://doaj.org/article/abf69ce417d94e56a77017f32616adc9
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Peripheral arterial disease in the elderly
por: Wilbert S Aronow
Publicado: (2008)

Anticoagulation in Peripheral Artery Disease: Are We There Yet?
por: Alessandro Cannavale, et al.
Publicado: (2020)

Management of peripheral arterial disease in the elderly: focus on cilostazol
por: Travis M Falconer, et al.
Publicado: (2008)

Statins and Peripheral Arterial Disease: A Narrative Review
por: Sergio Jansen-Chaparro, et al.
Publicado: (2021)

Precision delivery of liquid therapy into the arterial wall for the treatment of peripheral arterial disease
por: Marzieh K. Atigh, et al.
Publicado: (2021)

Autologous bone marrow cell therapy for peripheral arterial disease
por: Botti C, et al.
Publicado: (2012)

Multidisciplinary approach to the diagnosis and management of patients with peripheral arterial disease
por: Walker CM, et al.
Publicado: (2015)

The Role of Atherectomy in Peripheral Artery Disease: Current Evidence and Future Perspectives
por: Grigorios Korosoglou, et al.
Publicado: (2019)

Exercise-Induced Plasma Metabolomic Profiles in Patients With Peripheral Arterial Disease
por: Wendsèndaté Yves Semporé, et al.
Publicado: (2021)

Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
por: Vadim V. Genkel, et al.
Publicado: (2018)

Adherence to Statin Therapy Drives Survival of Patients with Symptomatic Peripheral Artery Disease
por: J Dopheide, et al.
Publicado: (2020)

Hybrid Nitric Oxide Donor and its Carrier for the Treatment of Peripheral Arterial Diseases
por: Duong Q. Le, et al.
Publicado: (2017)

Combination of Exercise Testing Criteria to Diagnose Lower Extremity Peripheral Artery Disease
por: Olivier Stivalet, et al.
Publicado: (2021)

Critical evaluation of stents in the peripheral arterial disease of the superficial femoral artery – focus on the paclitaxel eluting stent
por: Litsky J, et al.
Publicado: (2014)

Influenza vaccination reduces incidence of peripheral arterial occlusive disease in elderly patients with chronic kidney disease
por: Ping-Jen Hu, et al.
Publicado: (2021)

Paclitaxel- and Sirolimus-coated Balloons in Peripheral Artery Disease Treatment: Current Perspectives and Concerns
por: Masayuki Mori, et al.
Publicado: (2021)

Association of sleep apnea with outcomes in peripheral artery disease: Insights from the PORTRAIT study.
por: Qurat-Ul-Ain Jelani, et al.
Publicado: (2021)

Variability in Annual Fasting Glucose and the Risk of Peripheral Artery Disease in Patients with Diabetes Mellitus
por: Chang YS, et al.
Publicado: (2021)

Mortality is not associated with paclitaxel-coated devices usage in peripheral arterial disease of lower extremities
por: Dai Sik Ko, et al.
Publicado: (2021)

Paclitaxel Exposure and Dosage of Drug-coated Devices for the Treatment of Femoropopliteal Peripheral Artery Disease
por: Ceazón T Edwards, et al.
Publicado: (2021)

Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease.
por: Bader Alsuwailem, et al.
Publicado: (2021)

Diabetes Mellitus and Its Impact on Patient-Profile and In-Hospital Outcomes in Peripheral Artery Disease
por: Karsten Keller, et al.
Publicado: (2021)

New developments in the clinical use of drug-coated balloon catheters in peripheral arterial disease
por: Naghi J, et al.
Publicado: (2016)

Author Correction: Clinical validation of smartphone-based activity tracking in peripheral artery disease patients
por: Raheel Ata, et al.
Publicado: (2020)

Comparison of long-term outcomes after directional versus rotational atherectomy in peripheral artery disease
por: Adam Janas, et al.
Publicado: (2020)

Low mean platelet volume is associated with critical limb ischemia in peripheral arterial occlusive disease
por: Peter Rief, et al.
Publicado: (2018)

Peripheral artery disease at the time of dialysis initiation and mortality: a prospective observational multicenter study
por: Shoichi Maruyama, et al.
Publicado: (2020)

IN.PACTTM AdmiralTM drug-coated balloons in peripheral artery disease: current perspectives
por: Torii S, et al.
Publicado: (2019)

Retinal and choriocapillaris perfusion are associated with ankle-brachial-pressure-index and Fontaine stage in peripheral arterial disease
por: Maximilian W. M. Wintergerst, et al.
Publicado: (2021)

Immediate results and long-term cardiovascular outcomes of endovascular therapy in octogenarians and nonoctogenarians with peripheral arterial diseases
por: Huang HL, et al.
Publicado: (2016)

Induced endothelial cells from peripheral arterial disease patients and neonatal fibroblasts have comparable angiogenic properties.
por: Jack D Hywood, et al.
Publicado: (2021)

Heart Rate Predicts the Risk of New-Onset Peripheral Arterial Disease in a Community-Based Population in China
por: Gao Y, et al.
Publicado: (2021)

The prognostic role of RBP-4 and adiponectin in patients with peripheral arterial disease undergoing lower limb endovascular revascularization
por: Nikolaos P. E. Kadoglou, et al.
Publicado: (2021)

Beyond the Patient’s Report: Self-Reported, Subjective, Objective and Estimated Walking Disability in Patients with Peripheral Artery Disease
por: Nicola Lamberti, et al.
Publicado: (2021)

Association between ankle brachial index and development of postoperative intensive care unit delirium in patients with peripheral arterial disease
por: Jihee Kang, et al.
Publicado: (2021)

Joint Effects of Plasma Homocysteine Concentration and Traditional Cardiovascular Risk Factors on the Risk of New-Onset Peripheral Arterial Disease
por: Liu M, et al.
Publicado: (2020)

Profile of Peripheral Arterial Disease in Type 2 Diabetes Mellitus - A Hospital-based observational study in Coastal Karnataka
por: Esha Arora, et al.
Publicado: (2020)

Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease
por: Abdelrahman Zamzam, et al.
Publicado: (2021)

Quality assessment and comparative analysis on the recommendations of current guidelines on the management of peripheral arterial disease: a systematic review protocol
por: Oliseneku Damien Uyagu, et al.
Publicado: (2021)

Electronegative low-density lipoprotein increases the risk of ischemic lower-extremity peripheral artery disease in uremia patients on maintenance hemodialysis
por: Chiz-Tzung Chang, et al.
Publicado: (2017)